Author Topic: Cladribine (Mavenclad) approved for active SPMS, RRMS  (Read 160 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
Cladribine (Mavenclad) approved for active SPMS, RRMS
« on: April 01, 2019, 04:00:21 pm »
Another MS drug has been approved. Like siponimod (Mayzent), it turns out to be for SPMS only if it's still active SPMS (still having relapses). From the MSAA (April 1, 2019):


https://mymsaa.org/mavenclad-approved-fda/?utm_source=latest_news&utm_medium=email&utm_campaign=mavenclad_approval&utm_content=email_body
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
20 Replies
935 Views
Last post July 09, 2019, 08:59:28 am
by agate
0 Replies
122 Views
Last post September 17, 2016, 02:32:48 pm
by agate
1 Replies
244 Views
Last post June 29, 2018, 09:17:32 pm
by agate
0 Replies
103 Views
Last post October 31, 2019, 08:49:09 am
by agate
0 Replies
70 Views
Last post January 29, 2020, 09:35:32 pm
by agate